Investigating the role of TL1A-DR3 in immune complex-mediated autoimmune disease. (360G-Wellcome-106809_Z_15_Z)

£80,000

In this project we propose to focus on the role of the DR3-TL1A axis in autoimmune disease and more specifically on its involvement in lupus nephritis. We will determine which subset of kidney-resident mononuclear phagocytes express TL1A following immune complex-dependent FcγR-cross-linking. We will also investigate the relative importance of DR3 expression on myeloid cells versus lymphocytes in disease pathogenesis. Finally we will address how the myeloid cells and lymphocytes interact in the kidney in vivo and determine the role of the DR3-TL1A axis in these interactions

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region East of England
Award Date 2015-01-12T00:00:00+00:00
Sponsor(s) Prof Menna Clatworthy
Internal ID 106809/Z/15/Z
Planned Dates: End Date 2019-09-30T00:00:00+00:00
Planned Dates: Start Date 2015-10-01T00:00:00+00:00
Amount Awarded 80000
Financial Year 2014/15
Lead Applicant Mr Nathan Richoz
Grant Programme: Title WT/NIH Four Year PhD Studentship
Partnership Name Wellcome Trust-NIH PhD Studentships
Applicant Surname Richoz
Approval Committee WT/NIH Four Year PhD Programme Interview Committee
Recipient Org: Country United Kingdom
Recipient Org: City Cambridge
Has the grant transferred? No
Research conducted at multiple locations? No
Total amount including partnership funding 80000